These genomic alterations were mostly amplifications in the case of EIF4A3, RBM3 and SRPK, which are overexpressed in HCC and deep deletions in the case of ESRP2, which is downregulated in HCC samples. This evidence concerns the gene RBM3 and hepatocellular carcinoma.